Choice of contrast enhancement index for dynamic magnetic resonance mammography

Indices are often used in dynamic MRI of the breast to quantitate signal enhancement within suspicious lesions. Two indices are commonly used: one calculates the difference in pre- and postcontrast signal intensity, normalised to a base-line signal intensity such as that of fat (which does not enhance) whilst the other calculates the ratio of pre- to postcontrast signal intensity. The results of a computational simulation are presented which demonstrate the superiority of the normalised signal difference index, based on the criterion that the best index is that which is least influenced by initial tissue T1. This hypothesis was tested by comparing the two indices in a group of patients with clinical or mammographic suspicion of recurrent breast carcinoma. Of 37 patient examinations using Gadolinium enhanced MRI of the breast, 11 patients showed 13 lesions with some degree of enhancement, which were subsequently diagnosed histologically as either benign or malignant. The normalised signal difference index showed no overlap between the benign and malignant groups, whereas some overlap was observed with the signal ratio index. The clinical findings are therefore consistent with the results of the computational simulation.